What is CVE-2007-6763?

CVE-2007-6763 is a high-severity vulnerability in Sas Drug Development, classified under Improper Input Validation. CVSS score: 8.8/10. Published 2019-07-31.

How severe is CVE-2007-6763?

High severity. CVSS v3 base score is 8.8 out of 10.

Improper input validation in Sas Drug Development

CVE-2007-6763

SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.

Vulnerability class: Drupalgeddon 2 (CVE-2018-7600)

EPSS: 0.013 (67.9th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 8.8 (High). Vector: CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.

Affected products

Sas Sas_drug_development
N/a — versions n/a

Weakness classification (CWE)

CWE-20 — Improper Input Validation

References

cve@mitre.org (x_refsource_MISC, Vendor Advisory)

Frequently asked questions

What is CVE-2007-6763?: CVE-2007-6763 is a high-severity vulnerability in Sas Drug Development, classified under Improper Input Validation. CVSS score: 8.8/10. Published 2019-07-31.
How severe is CVE-2007-6763?: High severity. CVSS v3 base score is 8.8 out of 10.